Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer
Ceritinib was highly active in patients with advanced, ALK-rearranged NSCLC, including those who had had disease progression during crizotinib treatment, regardless of the prese...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 1,444
- Institution
- Seoul National University Hospital
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.